Previous 10 | Next 10 |
Tenet Healthcare Corporation (NYSE: THC) today announced the pricing of the previously announced private placement offering and has agreed to issue and sell $1.350 billion in aggregate principal amount of senior secured first lien notes due on May 15, 2031, which will bear interest at a rate of 6...
2023-05-02 08:31:42 ET Tenet Healthcare ( NYSE: THC ) announced a private placement offering of $1.35B in aggregate principal amount of new senior secured first lien notes maturing in 2031. Net proceeds from the sale of the notes, after payment of fees and expenses, to fin...
Tenet Healthcare Corporation (NYSE: THC) today announced a private placement offering of $1.350 billion in aggregate principal amount of new senior secured first lien notes maturing in 2031 (the “notes”). Completion of the notes offering is subject to, among other things, pricing an...
2023-05-02 02:44:00 ET Summary Green Light Capital is a privately owned hedge fund sponsor. The firm invests in the public equity and fixed income markets of the United States. It primarily invests in value. The Greenlight Capital funds returned (1.3%) in the first quarter of 2023...
2023-04-29 19:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Tenet Healthcare Corporation (NYSE: THC) is scheduled to present at the BofA Securities 2023 Health Care Conference in Las Vegas, NV, on Tuesday, May 9, 2023, beginning at 9:20 a.m. Pacific time (12:20 p.m. Eastern Time). A live webcast and audio archive of the call may be accessed through th...
2023-04-25 16:35:42 ET Tenet Healthcare Corporation (THC) Q1 2023 Earnings Conference Call April 25, 2023 10:00 AM ET Company Participants Will McDowell - Vice President, Investor Relations Saum Sutaria - Chief Executive Officer Daniel Cancelmi - Chief Financial ...
2023-04-25 08:29:42 ET Baudax Bio ( BXRX ) -74% announces positive top-line final results from phase 2 randomized clinical trial of BX1000. Morphic Holding ( MORF ) -34% as lead asset meets key goal in mid-stage trial. CXApp ( CXAI ) -32% . ZeroFox ...
2023-04-25 08:29:42 ET Baudax Bio ( BXRX ) +74% announces positive top-line final results from phase 2 randomized clinical trial of BX1000. Morphic Holding ( MORF ) +34% as lead asset meets key goal in mid-stage trial. CXApp ( CXAI ) +32% . ZeroFox ...
2023-04-25 07:01:18 ET Tenet Healthcare press release ( NYSE: THC ): Q1 Non-GAAP EPS of $1.42 beats by $0.27 . Revenue of $5.02B (+5.7% Y/Y) beats by $170M . Consolidated Adjusted EBITDA in first quarter 2023 of $832 million, including $3 million of grant incom...
News, Short Squeeze, Breakout and More Instantly...
Tenet Healthcare Corporation Company Name:
THC Stock Symbol:
NYSE Market:
Tenet Healthcare Corporation Website:
2024-07-19 10:32:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-10 07:00:09 ET Andrew Mok from Barclays issued a price target of $156.00 for THC on 2024-07-10 05:58:00. The adjusted price target was set to $156.00. At the time of the announcement, THC was trading at $130.97. The overall price target consensus is at $115.60 wi...